Wockhardt Gains On U.K. Regulator’s Clean Chit For Chikalthana Facility
Wockhardt’s Chikalthana facility GMP compliant says U.K. regulator.
- Wockhardt’s Chikalthana facility GMP compliant: U.K. regulator.
- Inspection frequency reduced to one per year from two per year currently.
- Stock rallied as much as 3.1 percent to Rs 704.
Drug firm Wockhardt Ltd. said that the U.K. health regulator has confirmed that its manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).
"U.K. MHRA (U.K. Medicines and Healthcare products Regulatory Agency) has since confirmed that general compliance with the principles and guidelines of Good Manufacturing Practice of the company's manufacturing unit at L-1, Chikalthana, Aurangabad," Wockhardt said in a filing to BSE. In view of this, the approval status of the said unit continues, it added.
"Further, U.K. MHRA has considered the said manufacturing unit suitable for risk based inspection with reduced inspection frequency of two years from the existing inspection frequency of 1 year," Wockhardt said.
